drugset / Trial / NCT07097922

Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients With Dry Eye After LASIK

NCT07097922

Not yet recruiting 140 enrolled He Eye Hospital
RandomizedParallel-groupSingle-blindOther

Summary

The prevalence of refractive ametropia is rising year by year. Refractive surgery has become the main approach for adults to correct refractive ametropia, and postoperative complications have aroused extensive attention from clinicians. Dry eye after refractive surgery is one of the postoperative complications, which is an important cause of affecting the postoperative visual quality and satisfaction of patients. It was reported that 3% diquafosol (DQS) and 0.1% hyaluronic acid (HA) can relieve dry eye symptoms. This study aims to compare the efficacy of 3% DQS and 0.1% HA in treating dry eye after LASIK

Timeline

Start
2025-08-01
Primary completion
2026-05-01
Completion
2026-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Diquafosol Oligonucleotide (other) 3 % Topical
Subject Sodium Hyaluronate Other / unclassified 0.1 % Topical

Indications